BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11889897)

  • 1. Section 1A: Rh serology. Coordinator's report.
    Scott M
    Transfus Clin Biol; 2002 Jan; 9(1):23-9. PubMed ID: 11889897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rh serology--coordinator's report.
    Scott M
    Transfus Clin Biol; 1996; 3(6):333-7. PubMed ID: 9018785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination.
    Flegel WA; Curin-Serbec V; Delamaire M; Donvito B; Ikeda H; Jørgensen J; Kumpel B; Le Pennec PY; Písacka M; Tani Y; Uchikawa M; Wendel S; Wagner FF
    Transfus Clin Biol; 2002 Jan; 9(1):33-42. PubMed ID: 11889898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs.
    Noizat-Pirenne F; Ansart-Pirenne H; Ménanteau C; Braddock D; Rouzaud AM; Klein MT; Patereau C; Rouger P; Le Pennec PY
    Transfus Clin Biol; 2003 Oct; 10(5):319-23. PubMed ID: 14572547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
    Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
    Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Section 5: Structural/genetic analysis of mAbs to blood group antigens. Coordinator's report.
    Siegel DL; Czerwinski M; Spitalnik SL
    Transfus Clin Biol; 2002 Jan; 9(1):83-97. PubMed ID: 11889903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISBT monoclonal antibody workshop: report on group 3 (anti-Rh) antibodies.
    Lubenko A; Burslem SJ; Tandy J; Contreras M; Garner SF; Wiener E
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):145-52. PubMed ID: 3145543
    [No Abstract]   [Full Text] [Related]  

  • 8. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Sandler SG; Flegel WA; Westhoff CM; Denomme GA; Delaney M; Keller MA; Johnson ST; Katz L; Queenan JT; Vassallo RR; Simon CD;
    Transfusion; 2015 Mar; 55(3):680-9. PubMed ID: 25438646
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
    León-González G; Cruz C
    Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serologically defined Rh determinants.
    Tippett P
    J Immunogenet; 1990; 17(4-5):247-57. PubMed ID: 1709668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of an anti-D monoclonal antibody using unconventional techniques].
    Almará A; Biondi C; García Rosasco M; Racca A; Morisoli L; Valverde J
    Sangre (Barc); 1993 Feb; 38(1):69. PubMed ID: 8385809
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype.
    Lai M; Grasso C; Boschi I; D'Onofrio G; Pascali V; Leone G
    Transfusion; 2009 May; 49(5):937-42. PubMed ID: 19175552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological characterization of 18 monoclonal antibodies directed against Rh, G and LW molecules.
    Le Pennec PY; Klein MT; Le Besnerais M; Tsikas G; Champomier F; Goossens D; Rouger P
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):123-31. PubMed ID: 3145540
    [No Abstract]   [Full Text] [Related]  

  • 16. Section 3: Epitope determination of monoclonal antibodies to glycophorin A and glycophorin B. Coordinator's report. Antibodies to antigens located on glycophorins and band 3.
    Reid ME; Lisowska E; Blanchard D
    Transfus Clin Biol; 2002 Jan; 9(1):63-72. PubMed ID: 11889901
    [No Abstract]   [Full Text] [Related]  

  • 17. Initial identification and mapping of distinct Rh0 (D) epitopes.
    Rodriguez L; Winn L; Foung SK
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):223-31. PubMed ID: 2463657
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences in the characteristics of human monoclonal and polyclonal anti-D as revealed by immunochemical investigations: human monoclonal antibodies share specificities with natural antibodies.
    Thorpe SJ; Bailey SW; Gooi HC; Thompson KM
    Transfus Med; 1992 Jun; 2(2):151-7. PubMed ID: 1284979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FPTT is a low-incidence Rh antigen associated with a "new" partial Rh D phenotype, DFR.
    Lomas C; Grässmann W; Ford D; Watt J; Gooch A; Jones J; Beolet M; Stern D; Wallace M; Tippett P
    Transfusion; 1994 Jul; 34(7):612-6. PubMed ID: 7519797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the epitopes recognized by monoclonal anti-D, anti-c and anti-E.
    Hughes-Jones NC; Gorick B; McDougall D; Melamed M; Thompson K
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):233-6. PubMed ID: 2463658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.